So depression is an inflammatory disease, but where does the inflammation come from? - PubMed (original) (raw)
Review
So depression is an inflammatory disease, but where does the inflammation come from?
Michael Berk et al. BMC Med. 2013.
Abstract
Background: We now know that depression is associated with a chronic, low-grade inflammatory response and activation of cell-mediated immunity, as well as activation of the compensatory anti-inflammatory reflex system. It is similarly accompanied by increased oxidative and nitrosative stress (O&NS), which contribute to neuroprogression in the disorder. The obvious question this poses is 'what is the source of this chronic low-grade inflammation?'
Discussion: This review explores the role of inflammation and oxidative and nitrosative stress as possible mediators of known environmental risk factors in depression, and discusses potential implications of these findings. A range of factors appear to increase the risk for the development of depression, and seem to be associated with systemic inflammation; these include psychosocial stressors, poor diet, physical inactivity, obesity, smoking, altered gut permeability, atopy, dental cares, sleep and vitamin D deficiency.
Summary: The identification of known sources of inflammation provides support for inflammation as a mediating pathway to both risk and neuroprogression in depression. Critically, most of these factors are plastic, and potentially amenable to therapeutic and preventative interventions. Most, but not all, of the above mentioned sources of inflammation may play a role in other psychiatric disorders, such as bipolar disorder, schizophrenia, autism and post-traumatic stress disorder.
Similar articles
- Sleep disturbance, inflammation and depression risk in cancer survivors.
Irwin MR, Olmstead RE, Ganz PA, Haque R. Irwin MR, et al. Brain Behav Immun. 2013 Mar;30 Suppl(Suppl):S58-67. doi: 10.1016/j.bbi.2012.05.002. Epub 2012 May 24. Brain Behav Immun. 2013. PMID: 22634367 Free PMC article. Review. - Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways.
Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Maes M, et al. Neuro Endocrinol Lett. 2011;32(1):7-24. Neuro Endocrinol Lett. 2011. PMID: 21407167 Review. - Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders.
Morris G, Puri BK, Walker AJ, Maes M, Carvalho AF, Bortolasci CC, Walder K, Berk M. Morris G, et al. Neurosci Biobehav Rev. 2019 Dec;107:862-882. doi: 10.1016/j.neubiorev.2019.09.025. Epub 2019 Sep 20. Neurosci Biobehav Rev. 2019. PMID: 31545987 Review. - Role of Adiposity-Driven Inflammation in Depressive Morbidity.
Capuron L, Lasselin J, Castanon N. Capuron L, et al. Neuropsychopharmacology. 2017 Jan;42(1):115-128. doi: 10.1038/npp.2016.123. Epub 2016 Jul 11. Neuropsychopharmacology. 2017. PMID: 27402495 Free PMC article. Review.
Cited by
- Biomarkers Unveiling the Interplay of Mind, Nervous System, and Immunity.
Doifode T, Maziero MP, Quevedo J, Barichello T. Doifode T, et al. Methods Mol Biol. 2025;2868:73-90. doi: 10.1007/978-1-0716-4200-9_5. Methods Mol Biol. 2025. PMID: 39546226 Review. - Tobacco Smoke Exposure in Children and Adolescents: Prevalence, Risk Factors and Co-Morbid Neuropsychiatric Conditions in a US Nationwide Study.
Salehi M, Saeidi M, Kasulis N, Barias T, Kainth T, Gunturu S. Salehi M, et al. Healthcare (Basel). 2024 Oct 22;12(21):2102. doi: 10.3390/healthcare12212102. Healthcare (Basel). 2024. PMID: 39517315 Free PMC article. - A follow-up study with a double-blinded, randomized controlled vitamin D supplementation trial in patients with major depressive episode (DepFuD): A study protocol and baseline characteristics.
Mikola T, Lehto SM, Honkalampi K, Valkonen-Korhonen M, Koivumaa-Honkanen H, Tolmunen T, Laukkanen V, Pakarinen M, Ruusunen A. Mikola T, et al. Food Sci Nutr. 2024 Aug 20;12(10):8454-8469. doi: 10.1002/fsn3.4417. eCollection 2024 Oct. Food Sci Nutr. 2024. PMID: 39479665 Free PMC article. - Associations between Sjogren syndrome and psychiatric disorders in European populations: a 2-sample bidirectional Mendelian randomization study.
Pan L, Zhou G, Wei G, Zhao Q, Wang Y, Chen Q, Xiao Q, Song Y, Liang X, Zou Z, Li X, Xiong X. Pan L, et al. Front Psychiatry. 2024 Oct 16;15:1465381. doi: 10.3389/fpsyt.2024.1465381. eCollection 2024. Front Psychiatry. 2024. PMID: 39479595 Free PMC article. - Association of Neutrophil-Percentage-To-Albumin Ratio(NPAR) with depression symptoms in U.S. adults: a NHANES study from 2011 to 2018.
Zhu Y, Fu Z. Zhu Y, et al. BMC Psychiatry. 2024 Oct 28;24(1):746. doi: 10.1186/s12888-024-06178-0. BMC Psychiatry. 2024. PMID: 39468499 Free PMC article.
References
- Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19:11–38. - PubMed
- Moylan S, Maes M, Wray NR, Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry. 2012;18:595–606. - PubMed
- Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. 2012;36:764–785. - PubMed
- Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446–457. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous